Matches in Wikidata for { <http://www.wikidata.org/entity/Q56958802> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q56958802 description "artículu científicu espublizáu en mayu de 2017" @default.
- Q56958802 description "im Mai 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56958802 description "scientific article published on 06 May 2017" @default.
- Q56958802 description "wetenschappelijk artikel" @default.
- Q56958802 description "наукова стаття, опублікована в серпні 2017" @default.
- Q56958802 name "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 name "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 type Item @default.
- Q56958802 label "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 label "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 prefLabel "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 prefLabel "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 P1433 Q56958802-F492E7BC-5B91-4F02-BBF3-AEEB88B1CA06 @default.
- Q56958802 P1476 Q56958802-215516CE-6495-49B3-BA45-C2A3C67BABDA @default.
- Q56958802 P2093 Q56958802-3253C0DD-7B42-49EB-B53D-5768918CCF0B @default.
- Q56958802 P2093 Q56958802-60945357-3851-45D4-861A-711618694970 @default.
- Q56958802 P2093 Q56958802-725539B9-D522-47ED-ACD8-80964ADDE873 @default.
- Q56958802 P2093 Q56958802-D4478B2A-9095-4B04-99A7-1369316E3185 @default.
- Q56958802 P304 Q56958802-7421E082-DD3D-447C-82EA-A29ED288E94E @default.
- Q56958802 P31 Q56958802-CB408922-3DC9-4C3B-9030-2464F4909086 @default.
- Q56958802 P356 Q56958802-3C4AE33C-8C00-4A92-B9A1-C525F672FB59 @default.
- Q56958802 P407 Q56958802-6E37CA77-EB3B-4C79-964B-367DAFBC7132 @default.
- Q56958802 P433 Q56958802-101D2DDD-5A3F-457D-BA12-0BE19E196308 @default.
- Q56958802 P478 Q56958802-27217198-F0EE-4EA6-96A4-CCEF8C2E508C @default.
- Q56958802 P50 Q56958802-EF7D8764-23EB-4F33-9A98-B5070159804A @default.
- Q56958802 P577 Q56958802-754422E4-AB54-4B23-BE53-E1410022B7A5 @default.
- Q56958802 P698 Q56958802-E07765C9-4908-4EF3-8C16-D983B729AC7E @default.
- Q56958802 P921 Q56958802-9487F00F-EEAF-48F4-BAD2-82DADBD6ADC4 @default.
- Q56958802 P356 J.DLD.2017.04.022 @default.
- Q56958802 P698 28546063 @default.
- Q56958802 P1433 Q15766194 @default.
- Q56958802 P1476 "Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials" @default.
- Q56958802 P2093 "Francesco Giuseppe Foschi" @default.
- Q56958802 P2093 "Giorgio Ercolani" @default.
- Q56958802 P2093 "Giovanni Luca Frassineti" @default.
- Q56958802 P2093 "Paola Ulivi" @default.
- Q56958802 P304 "943-944" @default.
- Q56958802 P31 Q13442814 @default.
- Q56958802 P356 "10.1016/J.DLD.2017.04.022" @default.
- Q56958802 P407 Q1860 @default.
- Q56958802 P433 "8" @default.
- Q56958802 P478 "49" @default.
- Q56958802 P50 Q42838004 @default.
- Q56958802 P577 "2017-05-06T00:00:00Z" @default.
- Q56958802 P698 "28546063" @default.
- Q56958802 P921 Q1148337 @default.